CIK 0001802665
- Large accelerated filer
Harmony Biosciences Holdings, Inc.
Sign in to watch- Ticker
- HRMY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822279923
- Phone
- +1 484-539-9800
- Business address
- 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, 19462
- 4 Open-market sale President, CEO sold 15,000 shares at an average $45.42 ($681,277)
- 4 Open-market sale President, CEO sold 25,000 shares at an average $44.18 ($1,104,411)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 6,554 shares at $52.19 ($342,053)
- 4 Open-market sale Director sold 132,258 shares at an average $52.30 ($6,916,488)
- 4 Open-market sale Director sold 119,829 shares at an average $51.07 ($6,120,014)
- 4 Open-market sale Director sold 11,165 shares at an average $50.17 ($560,097)
- 4 Open-market sale Director sold 21,394 shares at an average $50.24 ($1,074,792)
- 4 Open-market sale Chief Commercial Officer sold 14,471 shares at an average $49.63 ($718,170)
- 4 Open-market sale Director sold 37,391 shares at an average $50.21 ($1,877,309)
- 4 Open-market sale Director sold 114,121 shares at an average $50.66 ($5,781,098)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 36,294 shares at an average $50.16 ($1,820,523)
- 4 Open-market sale Director sold 16,181 shares at an average $50.08 ($810,373)
- 4 Open-market sale President, CEO sold 15,000 shares at $45.32 ($679,821)
Page 7 of 11 · 213 filings